Innomar’s VP of commercial strategy and innovation discusses the shifting global landscape and building relationships with pharma manufacturers.
Jessica Lovett
Advertisement
Jessica Lovett is VP of commercial strategy and innovation at Innomar.
Articles by Jessica Lovett
Jessica Lovett, VP of commercial strategy and innovation at Innomar, discusses the importance of meeting the needs of everyone at the table.
Jessica Lovett, VP of commercial strategy and innovation at Innomar, explains how handling uncertainty comes down to discipline.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
3
How Pharma is Adjusting Strategies for Changing Dynamics at FDA
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5